Literature DB >> 29862149

Generation of urine-derived induced pluripotent stem cells from a patient with phenylketonuria.

Zijuan Qi1,2, Yazhou Cui2, Liang Shi2, Jing Luan2, Xiaoyan Zhou2, Jinxiang Han2.   

Abstract

The aim of the study was to establish an induced pluripotent stem cell line from urine-derived cells (UiPSCs) from a patient with phenylketonuria (PKU) in order to provide a useful research tool with which to examine the pathology of this rare genetic metabolic disease. Urine-derived epithelial cells (UCs) from a 15-year-old male patient with PKU were isolated and reprogrammed with integration-free episomal vectors carrying an OCT4, SOX2, KLF4, and miR-302-367 cluster. PKU-UiPSCs were verified as correct using alkaline phosphatase staining. Pluripotency markers were detected with real-time PCR and flow cytometry. Promoter methylation in two pluripotent genes, NANOG and OCT4, was analyzed using bisulphite sequencing. An embryoid body (EB) formation assay was also performed. An induced pluripotent stem cell line (iPSC) was generated from epithelial cells in urine from a patient with PKU. This cell line had increased expression of stem cell biomarkers, it efficiently formed EBs, it stained positive for alkaline phosphatase (ALP), and it had a marked decrease in promoter methylation in the NANOG and OCT4 genes. The PKU-UiPSCs created here had typical characteristics and are suitable for further differentiation.

Entities:  

Keywords:  Phenylketonuria; disease model; induced pluripotent stem cells; integration-free; urinary cells

Year:  2018        PMID: 29862149      PMCID: PMC5982629          DOI: 10.5582/irdr.2018.01032

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  28 in total

1.  Comparative transcriptomic analysis identifies reprogramming and differentiation genes differentially expressed in UiPSCs and ESCs.

Authors:  Liang Shi; Yazhou Cui; Xiaoyan Zhou; Jing Luan; Linli Wang; Jinxiang Han
Journal:  Biosci Trends       Date:  2017-05-20       Impact factor: 2.400

2.  Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients.

Authors:  Aarne Fleischer; Iván M Lorenzo; Esther Palomino; Trond Aasen; Fernando Gómez; Miguel Servera; Víctor J Asensio; Víctor Gálvez; Juan Carlos Izpisúa-Belmonte; Daniel Bachiller
Journal:  Stem Cell Res       Date:  2018-03-11       Impact factor: 2.020

3.  Human epithelial cells cultured from urine: growth properties and keratin staining.

Authors:  J S Felix; T T Sun; J W Littlefield
Journal:  In Vitro       Date:  1980-10

4.  Increased spontaneous osteoclastogenesis from peripheral blood mononuclear cells in phenylketonuria.

Authors:  F Porta; I Roato; A Mussa; M Repici; E Gorassini; M Spada; R Ferracini
Journal:  J Inherit Metab Dis       Date:  2008-10-17       Impact factor: 4.982

5.  Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells.

Authors:  Agamemnon E Grigoriadis; Marion Kennedy; Aline Bozec; Fiona Brunton; Gudrun Stenbeck; In-Hyun Park; Erwin F Wagner; Gordon M Keller
Journal:  Blood       Date:  2010-01-11       Impact factor: 22.113

Review 6.  Phenylketonuria: a review of current and future treatments.

Authors:  Naz Al Hafid; John Christodoulou
Journal:  Transl Pediatr       Date:  2015-10

7.  Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva.

Authors:  Jie Cai; Valeria V Orlova; Xiujuan Cai; Elisabeth M W Eekhoff; Keqin Zhang; Duanqing Pei; Guangjin Pan; Christine L Mummery; Peter Ten Dijke
Journal:  Stem Cell Reports       Date:  2015-11-26       Impact factor: 7.765

8.  The influence of parental food preference and neophobia on children with phenylketonuria (PKU).

Authors:  Sharon Evans; Anne Daly; Satnam Chahal; Catherine Ashmore; John MacDonald; Anita MacDonald
Journal:  Mol Genet Metab Rep       Date:  2017-10-31

9.  Influence of phenylketonuria's diet on dimethylated arginines and methylation cycle.

Authors:  Fernando Andrade; Olalla López-Suárez; Marta Llarena; María L Couce; Luis Aldámiz-Echevarría
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

10.  Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC.

Authors:  Bu-Yeo Kim; SangKyun Jeong; Seo-Young Lee; So Min Lee; Eun Jeong Gweon; Hyunjun Ahn; Janghwan Kim; Sun-Ku Chung
Journal:  Exp Mol Med       Date:  2016-06-03       Impact factor: 8.718

View more
  4 in total

Review 1.  Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature.

Authors:  Maria Sofia Falzarano; Alessandra Ferlini
Journal:  J Clin Med       Date:  2019-05-08       Impact factor: 4.241

2.  Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications.

Authors:  Aline Yen Ling Wang; Charles Yuen Yung Loh
Journal:  Cell Transplant       Date:  2019-11-14       Impact factor: 4.064

Review 3.  Urine-derived induced pluripotent/neural stem cells for modeling neurological diseases.

Authors:  Tianyuan Shi; Martin Cheung
Journal:  Cell Biosci       Date:  2021-05-13       Impact factor: 7.133

4.  In vitro induced pluripotency from urine-derived cells in porcine.

Authors:  Kaiana Recchia; Lucas Simões Machado; Ramon Cesar Botigelli; Naira Caroline Godoy Pieri; Gabriela Barbosa; Raquel Vasconcelos Guimarães de Castro; Mariana Groke Marques; Laís Vicari de Figueiredo Pessôa; Paulo Fantinato Neto; Flávio Vieira Meirelles; Aline Fernanda de Souza; Simone Maria Massami Kitamura Martins; Fabiana Fernandes Bressan
Journal:  World J Stem Cells       Date:  2022-03-26       Impact factor: 5.326

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.